Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) EBT Margin (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed EBT Margin for 7 consecutive years, with 214.09% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 51460.0% to 214.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 57.35% through Dec 2025, up 52566.0% year-over-year, with the annual reading at 57.24% for FY2025, 53582.0% up from the prior year.
  • EBT Margin for Q4 2025 was 214.09% at Beam Therapeutics, up from 1162.38% in the prior quarter.
  • The five-year high for EBT Margin was 214.09% in Q4 2025, with the low at 3339900.0% in Q1 2021.
  • Average EBT Margin over 5 years is 216873.41%, with a median of 618.17% recorded in 2024.
  • The sharpest move saw EBT Margin plummeted -287726667bps in 2021, then soared 333900364bps in 2022.
  • Over 5 years, EBT Margin stood at 126.71% in 2021, then plummeted by -47bps to 186.4% in 2022, then soared by 124bps to 45.59% in 2023, then plummeted by -759bps to 300.51% in 2024, then soared by 171bps to 214.09% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 214.09%, 1162.38%, and 1208.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.